Ganglion cell losses underlying visual field defects from experimental glaucoma

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 10, 1999, Pages 2242-2250

  Harwerth, Ronald S ^b   Carter Dawson, Louvenia ^a   Shen, Fran ^a   Smith III, Earl L ^c   Crawford, M L J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARGON LASER; ARTICLE; CELL LOSS; CONTROLLED STUDY; GLAUCOMA; MALE; NONHUMAN; PERIMETRY; PRIORITY JOURNAL; RETINA GANGLION CELL; RHESUS MONKEY; TRABECULAR MESHWORK; VISUAL FIELD DEFECT; VISUAL STIMULATION; VISUAL THRESHOLD;

ANIMALS; CELL COUNT; DISEASE MODELS, ANIMAL; GLAUCOMA; LASER SURGERY; MACACA MULATTA; MALE; PERIMETRY; RETINAL GANGLION CELLS; TRABECULAR MESHWORK; VISION DISORDERS; VISUAL FIELDS;

EID: 0344329377     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Anderson DR. Perimetry, With and Without Automation. 2nd ed. St. Louis: CV Mosby; 1987.
2. Johnson CA. Standardizing the measurement of visual fields for clinical research. Ophthalmology 1996;103:186-189.
3. Alexander LJ. Diagnosis and management of primary open-angle glaucoma. In: Classe JG, ed. Optometry Clinics. Norwalk: Appleton & Lange, 1991;1:19-102.
4. Quigley HA. Open-angle glaucoma. N Engl J Med. 1993;328:1097-1106.
5. Epstein DL. Primary open angle glaucoma. In: Epstein DL, Allingham RR, Schuman JS, eds. Chandler and Grant's Glaucoma. 4th ed. Baltimore: Williams & Wilkins; 1997:183-198.
6. Flammer J, Drance SM, Augustiny L, Funkhouser A. Quantification of glaucomatous visual field defects with automated perimetry. Invest Ophthalmol Vis Sci. 1985;26:176-181.
7. Heijl A, Lindgren G, Olsson J. A package for the statistical analysis of visual fields. Doc Ophthalmol. 1987;49:153-168.
8. Heijl A, Lindgren G, Olsson J. Reliability parameters in computerized perimetry. Doc Ophthalmol. 1987;49:595-600.
9. Wood JM, Bruce AS. The value of visual field indexes in screening and threshold testing of glaucoma. Glaucoma. 1993;15:140-146.
10. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1419-1428.
11. Katz J, Sommer A, Gaasterland DE, Anderson DR. Comparison of analytic algorithms for detecting visual field loss. Arch Ophthalmol. 1991;109:1684-1689.
12. Asman P, Heijl A. Glaucoma hemifield test. Arch Ophthalmol. 1992;110:812-819.
13. Asman P, Heijl A. Evaluation of methods for automated hemifield analysis in perimetry. Arch Ophthalmol. 1992;110:820-826.
14. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma, III: quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol. 1982;100:136-146.
15. Tate GW. The physiological basis for perimetry. In: Drance SM, Anderson DR, eds. Automatic Perimetry in Glaucoma: A Practical Guide. Orlando: Grune & Stratton; 1985:1-28.
16. Frisen L. High-pass resolution perimetry. Doc Ophthalmol. 1993; 83:1-25.
17. Bartz-Schmidt KU, Weber J. Comparison of spatial thresholds and intensity thresholds in glaucoma. Int Ophthalmol. 1993;17:171-178.
18. Quigley HA, Dunlelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107:453-464.
19. Gaasterland DE, Kupfer C. Experimental glaucoma in the rhesus monkey. Invest Ophthalmol. 1974;13:455-457.
20. Pederson JE, Gaasterland DE. Laser-induced primate glaucoma, I: progression of cupping. Arch Ophthalmol. 1984;102:1689-1692.
21. Quigley HA, Holman RM. Laser energy levels for trabecular meshwork damage in the primate eye. Invest Ophthalmol Vis Sci. 1987;24:1305-1307.
22. Harwerth RS, Smith EL, DeSantis L. Experimental glaucoma: perimetric field defects and intraocular pressure. J Glaucoma. 1997; 6:390-401.
23. Schumer RA, Podos SM. The nerve of glaucoma. Arch Ophthalmol. 1994;112:37-44.
24. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774-786.
25. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114:299-305.
26. Nickells RW. Retinal ganglion cell death in glaucoma: the how, the why, and the maybe. J Glaucoma. 1996;5:345-356.
27. Harwerth RS, Smith EL, DeSantis L. Behavioral perimetry in mon-keys. Invest Ophthalmol Vis Sci. 1993;34:31-40.
28. Harwerth RS, Smith EL, Chandler M. Progressive visual field defects from experimental glaucoma: measurements with white and colored stimuli. Optom Vis Sci. In press.
29. Hart WM, Silverman SE, Trick GL, Nesher R, Gordon MO. Glaucomatous visual field damage: luminance and color-contrast sensitivities. Invest Ophthalmol Vis Sci. 1990;31:359-367.
30. Sample PA, Weinreb RN. Color perimetry for assessment of primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1990;31: 1869-1875.
31. Johnson CA, Adams AJ, Casson EJ, Brandt JD. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol. 1993;111:645-650.
32. Wild JM, Moss ID, Whitaker D, O'Neill EC. The statistical interpretation of blue-on-yellow visual field loss. Invest Ophthalmol Vis Sci. 1995;36:1398-1410.
33. Johnson CA. Diagnostic value of short-wavelength automated perimetry. Curr Opin Ophthalmol. 1996;7:54-58.
34. Porciatti V, Di Bartolo E, Nardi MM, Fiorentini A. Responses to chromatic and luminance contrast in glaucoma: a psychophysical and electrophysiological study. Vision Res. 1997;37:1975-1987.
35. Johnson CA. The Glenn A. Fry Award Lecture: early losses of visual function in glaucoma. Optom Vis Sci. 1995;72:359-370.
36. Lynch S, Johnson CA, Demirel S. Is early damage in glaucoma selective for a particular cell type or pathway? In: Wall M, Heijl A, eds. Perimetry Update 1996/1997. Amsterdam: Kugler Publications; 1997:253-261.
37. Harwerth RS, Smith EL. Contrast sensitivity perimetry: investigations with degenerate gratings. In: Wall M, Heijl A, eds. Perimetry Update 1996/1997. Amsterdam: Kugler Publications; 1997:3-12.
38. Harwerth RS, Smith EL, DeSantis L. Mechanisms mediating visual detection in static perimetry. Invest Ophthalmol Vis Sci. 1993;34: 3011-3023.
39. Carter-Dawson L, Shen F, Harwerth RS, Smith EL, Crawford MLJ, Chuang A. Glutamine immunoreactivity in Muller cells of monkey eyes with experimental glaucoma. Exp Eye Res. 1998;66:537-545.
40. Shen FF. Retinal cell morphology and visual field defects in glaucomatous monkey eyes. Masters Thesis. Houston: University of Houston; 1994.
41. Wassle H, Grunert U, Rohrenbeck J, Boycott BB. Retinal ganglion cell density and cortical magnification factor in the primate. Vision Res. 1990;30:1897-1911.
42. Frishman LJ, Shen FF, Du L, et al. The scotopic electroretinogram of macaque after retinal ganglion cell loss from experimental glaucoma. Invest Ophthalmol Vis Sci. 1996;37:125-141.
43. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec. 1946;94:239-247.
44. Harwerth RS, Smith EL. The independence of perimetry thresholds. In: Wall M, Wild J, eds. Perimetry Update 1998/1999. Amsterdam: Kugler Publications. In press.
45. Quigley HA, Davis EB, Anderson DR. Descending optic nerve degeneration in primates. Invest Ophthalmol Vis Sci. 1977;16: 841-849.
46. Glovinsky Y, Quigley HA, Dunkelberger GR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 1991;32:484-491.
47. Desatnik H, Quigley HA, Glovinsky Y. Study of central retinal ganglion cell loss in experimental glaucoma in monkey eyes. J Glaucoma. 1996;5:46-53.
48. Mikelberg FS, Schulzer M, Drance SM, Lau W. The rate of progression of scotomas in glaucoma. Am J Ophthalmol. 1986;101:1-6.
49. Mikelberg FS, Yidegiligne HM, Schulzer M. Optic nerve axon count and axon diameter in patients with ocular hypertension and normal visual fields. Ophthalmology. 1995;102:342-348.
50. Sample PA, Madrid ME, Weinreb RN. Evidence for a variety of functional defects in glaucoma-suspect eyes. J Glaucoma. 1994; 3(suppl):S5-S17.
51. Johnson CA. Selective versus nonselective losses in glaucoma. J Glaucoma. 1994;3(suppl):S32-S44.
52. Weinreb RN, Shakba S, Sample PA. Association between quantitative nerve fiber layer measurement and visual field loss in glaucoma. Am J Ophthalmol. 1995;120:732-738.
53. Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci. 1997;38:413-425.
54. Sample PA, Bosworth CF, Weinreb RN. Short-wavelength automated perimetry and motion automated perimetry in patients with glaucoma. Arch Ophthalmol. 1997;115:1129-1133.
55. Teesalu P, Vihanninjoki K, Airaksinen J, Tuulonen A, Laara E. Correlation of blue-on-yellow visual fields with scanning confocal laser optic disc measurements. Invest Ophthalmol Vis Sci. 1997; 38:2452-2459.
56. Wall M, Brito CF, Kutzko K. Motion detection perimetry: properties and results. In: Wall M, Heijl A, eds. Perimetry Update 1996/ 1997. Amsterdam: Kugler Publications; 1997:21-33.
57. Quigley HA, Dunkelberger GR, Baginski TA, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology. 1988;95:357-363.